#USA #Clinical Trials #Conshohocken #Suvoda #Greenphire

Suvoda and Greenphire Join Forces for a Seamless Clinical Trial Experience

In a significant development within the field of clinical trial technology, Suvoda LLC has successfully completed its brand integration with Greenphire, merging both entities under the Suvoda umbrella. This strategic move, announced on September 24, 2025, follows a successful merger earlier in April 2025 and is set to revolutionize the way clinical trials are conducted by offering a comprehensive technological platform.

The integration combines the expertise and innovation of both companies, aiming to enhance the overall experience of running and participating in clinical trials. Central to this unified approach is the launch of a consolidated website that showcases the full suite of products available at suvoda.com and an updated social media presence that streamlines communication across platforms.

A Unified Approach to Clinical Trials

The newly formed platform focuses on delivering patient-centric solutions that not only simplify processes for participants and site operators but also improve operational efficiency and data quality. Jagath Wanninayake, CEO of Suvoda, emphasized the company's mission by stating, "Our goal is to ease the experience at every point in the patient journey—whether that's operational, logistical, or financial." This commitment to enhancing the clinical trial experience will be reflected in new branding that includes a harmonized color palette and logo across all products.

Suvoda's offering consists of eight integrated products that include:

• - IRT (Interactive Response Technology)
• - eCOA (Electronic Clinical Outcome Assessments)
• - Greenphire Patient Payments (formerly ClinCard)
• - Greenphire Travel (formerly Concierge Services and Connex)
• - eConsent
• - Scheduling (formerly ePatient)
• - Greenphire Clinical Finance Suite, which includes Site Payments (formerly eClinicalGPS) and Budgeting Benchmarking (formerly EnvisiX)

By unifying these solutions, clinical trial sites and sponsors can benefit from a single sign-on, providing a consistent user interface and a singular patient app. This means that all data will be accessible in real-time across various platforms, significantly enhancing the efficiency of trial management.

Future Directions and Global Reach

Looking ahead, Suvoda plans to unify all its offerings further, which will lead to seamless experiences for sponsors, sites, and patients. This integration is not merely a cosmetic change but rather an overarching strategy to improve interactions and the flow of information in clinical trials.

Additionally, Suvoda is committed to maintaining high customer satisfaction scores, which have consistently surpassed industry averages. This success contributes to the company's reputation, as it has been selected by trial sponsors and Contract Research Organizations (CROs) to support over 2000 trials worldwide, spanning more than 95 countries.

As clinical trials become increasingly intricate and time-sensitive, advancements in technology like those introduced through this merger are essential. Suvoda is dedicated to equipping its partners with the tools necessary to navigate these complexities efficiently.

About Suvoda

Suvoda stands as a pioneer in the realm of clinical trial technology, offering a unique real-time experience platform that empowers sponsors and CROs. By fostering connectivity and providing action-oriented software solutions, Suvoda ensures that even under time-sensitive conditions, critical studies continue to progress smoothly.

With headquarters just outside Philadelphia, Suvoda also maintains a global presence with offices in Portland, Barcelona, Bucharest, Iasi, and Tokyo. This expansive network assists in maintaining high levels of service and support that clients expect from a leader in clinical trial technology.

For more information, visit suvoda.com and follow Suvoda on LinkedIn for updates on their latest innovations and offerings.